Gestational diabetes

• No studies at this time, please check back later.

Family members

1. The San Antonio Family Assessment of Metabolic Risk Indicators in Youth IRB# 045-0024-092 No UHS number. Principal Investigator: R. Duggirala (210) 358-7550. Currently recruiting from parents who previously participated in the San Antonio Family Heart Study, the San Antonio Family Diabetes or Gallbladder Study or the Veterans Administration Genetic Epidemiology Study

2. Effect of Pioglitazone versus Placebo Treatment on the Delay and/or Prevention of Type 2 Diabetes Mellitus in Subjects at High Risk for the Development of the Disease. IRB# 023-5014-209. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.

3. Molecular Epidemiology of Type 2 Diabetes Mellitus in Mexican Americans. IRB# 923-5014-439. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.

Overweight

1. The Role of Inflammatory, Adipocytokines, and Insulin Signaling and Sensitivity in the Prevention of Type 2 Diabetes Mellitus in Hypertensive Subjects Treated with Valsartan. IRB# HSC20070065H. Principal Investigator: Ralph DeFronzo, MD
   
   
2. Effect of Pioglitazone versus Placebo Treatment on the Delay and/or Prevention of Type 2 Diabetes Mellitus in Subjects at High Risk for the Development of the Disease. IRB# 023-5014-209. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.